Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Donadelli

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Molecular Therapy. Oncology|October 2, 2025
Complex genetic landscape in CLL: Clinical impact on patients' survival and insights into the altered molecular pathwaysCarlo Caputo, Massimo Donadelli, Mariateresa Scupoli, et al.
Journal of Medicinal Chemistry|May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC ModelsAlessandra Fiore, Antonio Scarano, Giulia Antonini, et al.
International Journal of Molecular Sciences|December 30, 2020
Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of GemcitabineStefania Forciniti, Elisa Dalla Pozza, Maria Raffaella Greco, et al.
Scientific Reports|March 20, 2024
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progressionSimona Gambino, Francesca Maria Quaglia, Marilisa Galasso, et al.
Hematological Oncology|November 14, 2024
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic LeukemiaMarilisa Galasso, Vittoria Salaorni, Riccardo Moia, et al.
British Journal of Cancer|October 16, 2018
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O<sub>2-</sub>· production in cancer cellsMarco Cordani, Giovanna Butera, Ilaria Dando, et al.
Cell Death & Disease|October 28, 2025
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cellsFederica Danzi, Giovanna Butera, Damien Sutton, et al.
The American Journal of Pathology|September 5, 2012
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survivalAlessandra Rosati, Samantha Bersani, Francesca Tavano, et al.
Molecular Therapy. Nucleic Acids|April 23, 2019
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Mayra Rachele Zarone, Angela Lombardi, et al.
Molecular Therapy. Nucleic Acids|April 10, 2025
Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Mayra Rachele Zarone, Angela Lombardi, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Molecular Therapy. Oncology|October 2, 2025
Complex genetic landscape in CLL: Clinical impact on patients' survival and insights into the altered molecular pathwaysCarlo Caputo, Massimo Donadelli, Mariateresa Scupoli, et al.
Journal of Medicinal Chemistry|May 26, 2026
First-in-Class Covalent Inhibitors of PFKFB3: Discovery and Characterization in PDAC ModelsAlessandra Fiore, Antonio Scarano, Giulia Antonini, et al.
International Journal of Molecular Sciences|December 30, 2020
Extracellular Matrix Composition Modulates the Responsiveness of Differentiated and Stem Pancreatic Cancer Cells to Lipophilic Derivate of GemcitabineStefania Forciniti, Elisa Dalla Pozza, Maria Raffaella Greco, et al.
Scientific Reports|March 20, 2024
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progressionSimona Gambino, Francesca Maria Quaglia, Marilisa Galasso, et al.
Hematological Oncology|November 14, 2024
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic LeukemiaMarilisa Galasso, Vittoria Salaorni, Riccardo Moia, et al.
British Journal of Cancer|October 16, 2018
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O<sub>2-</sub>· production in cancer cellsMarco Cordani, Giovanna Butera, Ilaria Dando, et al.
Cell Death & Disease|October 28, 2025
Chemotherapy enhances HMGA1 secretion through the mutant p53-CK2 axis in pancreatic ductal adenocarcinoma cellsFederica Danzi, Giovanna Butera, Damien Sutton, et al.
The American Journal of Pathology|September 5, 2012
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survivalAlessandra Rosati, Samantha Bersani, Francesca Tavano, et al.
Molecular Therapy. Nucleic Acids|April 23, 2019
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Mayra Rachele Zarone, Angela Lombardi, et al.
Molecular Therapy. Nucleic Acids|April 10, 2025
Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple MyelomaGabriella Misso, Mayra Rachele Zarone, Angela Lombardi, et al.
Pageof 10